In this study, we first confirmed the overexpression of NKG2D ligands on glioblastoma cells and then constructed a classic second-generation NKG2D CAR using the extracellular domain NKG2D, followed by 4-1BB and CD3ζ. The gene discussed is CD247; the disease is glioblastoma.